Nature killer cell therapies catch up to CAR-T

From The Scientist, 1 April 2020: When the first anticancer therapies based on engineered T cells hit the market a few years ago, they offered the possibility of what would have once been perceived as a medical miracle: a one-shot cure for certain blood cancers. Chimeric antigen receptor (CAR) T cell therapies, as they are Continue reading Nature killer cell therapies catch up to CAR-T

Game-changing class of immunotherapy drugs lengthens melanoma survival rates

From Nature, 22 April 2020: When Jedd Wolchok began working in the area of melanoma 20 years ago, the average life expectancy for a patient with advanced disease was six or seven months. Now his waiting room is full of people coming back for their third or fourth year of follow-up, sharing their stories of Continue reading Game-changing class of immunotherapy drugs lengthens melanoma survival rates

Lung cancer immunotherapy: chemical tricks

From Nature Outlook, 11 September 2014: The immune system has evolved over millions of years to protect the human body against microbes, pathogens and parasites. Which makes it all the more puzzling to immunologists as to why, when it comes to helping the body defend itself against cancer, immunotherapy treatments designed to enhance the immune Continue reading Lung cancer immunotherapy: chemical tricks